Bristol-Myers Squibb Long-term marketable securities decreased by 7.6% to $366.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.4%, from $344.00M to $366.00M.
An increase indicates a long-term capital preservation strategy, while a decrease suggests the liquidation of long-term investments to fund operations or debt repayment.
This represents long-term investments in debt securities that the company intends to hold for more than one year. These...
Used by mature companies with strong cash flows to manage long-term liquidity and investment returns.
non_current_assets_available_for_sale_securities_debt_se_908f76| Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $364.00M | $367.00M | $357.00M | $324.00M | $320.00M | $344.00M | $346.00M | $406.00M | $396.00M | $366.00M |
| QoQ Change | — | — | +0.8% | -2.7% | -9.2% | -1.2% | +7.5% | +0.6% | +17.3% | -2.5% | -7.6% |
| YoY Change | — | — | — | — | — | -12.1% | -6.3% | -3.1% | +25.3% | +23.8% | +6.4% |